About Onyx Pharm
Onyx Pharm is a publicly listed company based in San Francisco (United States) founded in 1992. Kinase inhibitors for treating various cancers are developed. Onyx Pharm has completed 1 acquisition, including Proteolix. Its focus areas include Life Sciences, Oncology, Drugs and Pan Cancer. Its legal entity is Onyx Pharmaceuticals, Inc. Similar companies include TScan Therapeutics, GigaGen and Shattuck Labs; 3 of its 3 listed similar companies have raised funding.
Company details
Founded in 1992 in San Francisco, United States, Onyx Pharmaceuticals focused on oncology pharmaceuticals. Kinase inhibitors such as sorafenib for advanced renal cell carcinoma and liver cancer were advanced through phase III trials. Additional candidates included carfilzomib for multiple myeloma and regorafenib for metastatic colorectal cancer. Operations centered on cancer treatment development until acquisition by Amgen in October 2013.
- Headquarters San Francisco, United States
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website onyx-pharm.com
- Social Facebook
- Legal Name Onyx Pharmaceuticals, Inc
- Latest Funding Round$18M (USD), Post-IPO
Jan 2000
- Investments & Acquisitions
Funding Insights of Onyx Pharm
- Total Rounds 1
- Last Round Post-IPO — $18M
- First Round $18M
(Jan 2000)
All 1 funding rounds of Onyx Pharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2000 | $18M | Post-IPO | – | – | – |
Investments & Acquisitions by Onyx Pharm
Onyx Pharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Proteolix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Targeting protein degradation pathways using proteasome inhibitors to treat cancer. | proteolix.com | San Francisco, United States | 2003 | Oct 2009 | $276M |
Complete acquisition details for Onyx Pharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Onyx Pharm
4 dated milestones of Onyx Pharm across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Onyx Pharm is founded.
- Funding First funding round of $18.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Proteolix.
Similar companies to Onyx Pharm
Onyx Pharm has 3 listed similar companies in our database, 3 of them funded. They include TScan Therapeutics, GigaGen and Shattuck Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tscan.com | 1995 | Boston, United States | $158.3M | 154 | T cell-based treatments for immunological and oncological disorders are developed. | |
| gigagen.com | 2011 | San Francisco, United States | $36.13M | 36 | T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | |
| shattucklabs.com | 2016 | Austin, United States | $165.4M | 89 | An immunotherapy platform for oncology and other diseases is developed. |
Detailed similar companies of Onyx Pharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Onyx Pharm
Websites that share an audience with Onyx Pharm (onyx-pharm.com).
Websites whose visitors overlap most with Onyx Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| exelixis.com | 100% | 39.1K | #1,001,350 | View details | |
| celgene.com | 86% | View details | |||
| genaera.com | 81% | View details | |||
| immunogen.com | 81% | View details | |||
healcorp.net | healcorp.net | 81% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Onyx Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Onyx Pharm (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Onyx Pharm
Complete news archive for Onyx Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Onyx Pharm
Onyx Pharm was founded in 1992 and raised its 1st funding round 8 years after it was founded.
Onyx Pharm is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Founded in 1992 in San Francisco, United States, Onyx Pharmaceuticals focused on oncology pharmaceuticals. Kinase inhibitors such as sorafenib for advanced renal cell carcinoma and liver cancer were advanced through phase III trials. Additional candidates included carfilzomib for multiple myeloma and regorafenib for metastatic colorectal cancer. Operations centered on cancer treatment development until acquisition by Amgen in October 2013.
Onyx Pharm's top competitors include GigaGen, Shattuck Labs and TScan Therapeutics.
Onyx Pharm has made 1 acquisition, including Proteolix.
Onyx Pharm operates through Onyx Pharmaceuticals, Inc.